We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gold Nanoparticles Improve Cellular Signaling in Novel Heart Repair Tissue

By LabMedica International staff writers
Posted on 09 Oct 2014
An Israeli research team has developed a novel gold nanoparticle-based approach for repairing damaged heart tissue.

Human heart cells cultured on ECM (extracellular matrix) scaffoldings of animal origin (usually pig) form a tissue that generates its own electrical impulses and expands and contracts spontaneously. More...
However, residual proteins and antigens from animal sources can trigger pathogenic immune responses following implantation of these tissues.

Investigators at Tel Aviv University (Israel) avoided the immune response problem by constructing scaffolding from a patient's own stomach wall tissue. In a further refinement, they integrated gold nanoparticles into this hybrid cardiac tissue in order to optimize electrical signaling between the cells.

Results published in the September 1, 2014, online edition of the journal Nano Letters revealed that cardiac cells engineered within these hybrid scaffolds exhibited elongated and aligned morphology, massive striation, and organized connexin 43 electrical coupling proteins. Furthermore, the hybrid patches demonstrated superior function as compared to pristine patches, including a stronger contraction force, lower excitation threshold, and faster calcium transients.

"Our goal was twofold," said senior author Dr. Tal Dvir, professor of molecular microbiology and biotechnology at Tel Aviv University, "to engineer tissue that would not trigger an immune response in the patient and to fabricate a functional patch not beset by signaling or conductivity problems. To address our electrical signaling problem, we deposited gold nanoparticles on the surface of our patient-harvested matrix, "decorating" the biomaterial with conductors. The result was that the nonimmunogenic hybrid patch contracted nicely due to the nanoparticles, transferring electrical signals much faster and more efficiently than non-modified scaffolds. We now have to prove that these autologous hybrid cardiac patches improve heart function after heart attacks with minimal immune response. Then we plan to move it to large animals and after that, to clinical trials."

Related Links:
Tel Aviv University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.